University of Miami Miller School of Medicine GME Consortium Internal Medicine

Topics

• Atrial Fibrillation Management and Outcomes 42
• Neuroendocrine Tumor Research Advances 27
• Acute Myeloid Leukemia Research 26
• Cardiac Valve Diseases and Treatments 26
• Cardiac Arrhythmias and Treatments 24
• Colorectal Cancer Screening and Detection 23
• Cardiac pacing and defibrillation studies 21
• COVID-19 Clinical Research Studies 21
• Acute Ischemic Stroke Management 19
• Thyroid Cancer Diagnosis and Treatment 18
• Asthma and respiratory diseases 17
• Mechanical Circulatory Support Devices 15

Most cited

1. Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.

   The New England journal of medicine · 2025 · 127 citations · Bhavana Konda

2. Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial.

   The Lancet. Oncology · 2022 · 384 citations · Bhavana Konda

3. Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019.

   JAMA neurology · 2024 · 98 citations · Purva Sharma

4. Dabrafenib Versus Dabrafenib + Trametinib in BRAF-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial.

   Thyroid : official journal of the American Thyroid Association · 2022 · 134 citations · Bhavana Konda

5. Artificial Intelligence and Lung Cancer: Impact on Improving Patient Outcomes.

   Cancers · 2023 · 87 citations · Nakeya Dewaswala

6. Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement.

   The lancet. Diabetes & endocrinology · 2025 · 32 citations · Bhavana Konda